Indicated for adults who require insulin to manage diabetes, including both type 1 (T1D) and type 2 (T2D), the system includes a tubeless patch pump design with a 300-unit insulin reservoir that ...

Embecta has secured an FDA clearance for its first wearable insulin delivery system, with a patch pump designed for people with either Type 1 or Type 2 diabetes. The fully disposable device ...

Embecta Corp. focuses on diabetes products and recently received FDA approval for a new patch pump. Read why I'm neutral on ...

Embecta Corp. EMBC recently announced the receipt of 510(k) clearance from the FDA for its proprietary disposable patch pump ...

Recommended Reading Insulet expands Omnipod 5 pump to people with Type 2 diabetes Embecta received 510(k) clearance from the Food and Drug Administration on Friday for its first insulin patch pump.

The system includes a wearable, disposable patch pump that provides adjustable basal and bolus insulin for up to three days, depending on the needs of the user.

The FDA designated Abbott's recall of FreeStyle Libre 3 sensors as the most serious, class I type due to the risk for ...

This follows the recent FDA clearance of the MODD1 pump for insulin delivery in adults. Simultaneously, the company received FDA clearance to market its new MODD1 insulin patch pump in the United ...

Indicated for adults who require insulin to manage diabetes, including both type 1 (T1D) and type 2 (T2D), the system includes a tubeless patch pump design with a 300-unit insulin reservoir that was ...

This follows the recent FDA clearance of the MODD1 pump for insulin delivery in adults. Simultaneously, the company received FDA clearance to market its new MODD1 insulin patch pump in the United ...